ProfileGDS5822 / ILMN_2571733
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 17% 37% 8% 5% 5% 11% 20% 55% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 112.117
GSM1276600PDAC Late Ablation Control 219.337
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 18.38
GSM1276603PDAC Late Ablation 265
GSM1276604PDAC Late Ablation 35.75
GSM1303940PDAC Late Ablation_anti-CTLA4 11011
GSM1303941PDAC Late Ablation_anti-CTLA4 210.820
GSM1303942PDAC Late Ablation_anti-CTLA4 330.955